756PInterim results of fight-202, a phase II, open-label,...

Annals of Oncology 2018 / 10 Vol. 29; Iss. suppl_8

756PInterim results of fight-202, a phase II, open-label, multicenter study of INCB054828 in patients (pts) with previously treated advanced/metastatic or surgically unresectable cholangiocarcinoma (CCA) with/without fibroblast growth factor (FGF)/FGF receptor (FGFR) genetic alterations

Hollebecque, A, Borad, M, Sahai, V, Catenacci, D V T, Murphy, A, Vaccaro, G, Paulson, A, Oh, D-Y, Féliz, L, Lihou, C, Zhen, H, Abou-Alfa, G K
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
29
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdy282.139
Date:
October, 2018
File:
PDF, 79 KB
english, 2018
Conversion to is in progress
Conversion to is failed